Related references
Note: Only part of the references are listed.Novel plant virus-based vaccine induces protective cytotoxic T-lymphocyte-mediated antiviral immunity through dendritic cell maturation
Patrick Lacasse et al.
JOURNAL OF VIROLOGY (2008)
Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: Evidence for the critical function of multimerization
Jerome Denis et al.
VIROLOGY (2007)
Critical role of toll-like receptors and nucleotide oligomerisation domain in the regulation of health and disease
Jane A. Mitchell et al.
JOURNAL OF ENDOCRINOLOGY (2007)
Virus-like particles-flexible platforms for vaccine development
Bryce Chackerian
EXPERT REVIEW OF VACCINES (2007)
Self-assembling light-harvesting systems from synthetically modified tobacco mosaic virus coat proteins
Rebekah A. Miller et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Morphology and stability changes of recombinant TMV particles caused by a cysteine residue in the foreign peptide fused to the coat protein
Qiaoli Li et al.
JOURNAL OF VIROLOGICAL METHODS (2007)
Assembly of trans-encapsidated recombinant viral vectors engineered from Tobacco mosaic virus and Semliki Forest virus and their evaluation as immunogens
Mark L. Smith et al.
VIROLOGY (2007)
Designing recombinant vaccines with viral properties: A rational approach to more effective vaccines
Gary T. Jennings et al.
CURRENT MOLECULAR MEDICINE (2007)
The cross-priming pathway: A portrait of an intricate immune system
S. Basta et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2007)
Immunoabsorbent nanoparticles based on a tobamovirus displaying protein A
Stefan Werner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
TMV-peptide fusion vaccines induce cell-mediated immune responses and tumor protection in two murine models
Alison A. McCormick et al.
VACCINE (2006)
Chemical conjugate TMV - Peptide bivalent fusion vaccines improve cellular immunity and tumor protection
Alison A. McCormick et al.
BIOCONJUGATE CHEMISTRY (2006)
Protection of rabbits against cutaneous papillomavirus infection using recombinant tobacco mosaic virus containing L2 capsid epitopes
Kenneth E. Palmer et al.
VACCINE (2006)
Modified Tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications
Mark L. Smith et al.
VIROLOGY (2006)
A modified TMV-based vector facilitates the expression of longer foreign epitopes in tobacco
LB Jiang et al.
VACCINE (2006)
Targeting antigens to dendritic cells in vivo
Paul J. Tacken et al.
IMMUNOBIOLOGY (2006)
Ins and outs of dendritic cells
DH Schuurhuis et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2006)
Cross-presentation: underlying mechanisms and role in immune surveillance
KL Rock et al.
IMMUNOLOGICAL REVIEWS (2005)
Mechanisms of MHC class I-restricted antigen processing and cross-presentation
P Cresswell et al.
IMMUNOLOGICAL REVIEWS (2005)
Immunity in response to particulate antigen-delivery systems
T Storni et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
The interface between innate and adaptive immunity
K Hoebe et al.
NATURE IMMUNOLOGY (2004)
Vaccines that facilitate antigen entry into dendritic cells
A Gamvrellis et al.
IMMUNOLOGY AND CELL BIOLOGY (2004)
Cellular mechanisms governing cross-presentation of exogenous antigens
AL Ackerman et al.
NATURE IMMUNOLOGY (2004)
Affinity purification of streptavidin using tobacco mosaic virus particles as purification tags
V Negrouk et al.
ANALYTICAL BIOCHEMISTRY (2004)
Expression of foot-and-mouth disease virus epitopes in tobacco by a tobacco mosaic virus-based vector
LG Wu et al.
VACCINE (2003)
A chemoselective biomolecular template for assembling diverse nanotubular materials
M Demir et al.
NANOTECHNOLOGY (2002)
Expression and purification of a neuropeptide nocistatin using two related plant viral vectors
AAL Lim et al.
GENE (2002)
Plant viral genes in DNA idiotypic vaccines activate linked CD4+ T-cell mediated immunity against B-cell malignancies
N Savelyeva et al.
NATURE BIOTECHNOLOGY (2001)
Improving vaccine performance with adjuvants
FR Vogel
CLINICAL INFECTIOUS DISEASES (2000)
Immunization with a chimeric tobacco mosaic virus containing an epitope of outer membrane protein F of Pseudomonas aeruginosa provides protection against challenge with P-aeruginosa
J Staczek et al.
VACCINE (2000)
Share Paper
